ENTRY       D11570                      Drug
NAME        Risedronate sodium monohydrate
PRODUCT
  GENERIC   RISEDRONATE SODIUM (Teva Pharmaceuticals USA)
            RISEDRONATE SODIUM (Teva Pharmaceuticals USA)
FORMULA     C7H10NO7P2. Na. H2O
EXACT_MASS  322.9936
MOL_WEIGHT  323.1094
CLASS       Musculo-skeletal system agent
             DG03232  Osteoporosis agent
              DG01600  Bisphosphonate
REMARK      ATC code: M05BA07
            Chemical structure group: DG00786
            Product (DG00786): D00942<US> D03234<JP/US> D11570<US>
EFFICACY    Antiresorptive, Osteoporosis agent, Farnesylpyrophosphate synthetase inhibitor
  DISEASE   Osteoporosis [DS:H01593]
            Glucocorticoid-induced osteoporosis [DS:H01709]
            Paget's disease [DS:H00437]
COMMENT     Bisphosphonate
TARGET      FDPS [HSA:2224] [KO:K00787]
  PATHWAY   hsa00900(2224)  Terpenoid backbone biosynthesis
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M05 DRUGS FOR TREATMENT OF BONE DISEASES
               M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
                M05BA Bisphosphonates
                 M05BA07 Risedronic acid
                  D11570  Risedronate sodium monohydrate &lt;US&gt;
            USP drug classification [BR:br08302]
             Metabolic Bone Disease Agents
              Bisphosphonates
               Risedronate
                D11570  Risedronate sodium monohydrate
            Drug groups [BR:br08330]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               DG01600  Bisphosphonate
                DG00786  Risedronic acid
                 D11570  Risedronate sodium monohydrate
            Drug classes [BR:br08332]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               D11570  Risedronate sodium monohydrate
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Transferases (EC2)
               Alkyl/Aryl transferases
                FDPS
                 D11570  Risedronate sodium monohydrate &lt;US&gt;
            Drug groups [BR:br08330]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               DG01600  Bisphosphonate
                DG00786  Risedronic acid
DBLINKS     CAS: 353228-19-0
            PubChem: 384585545
ATOM        19
            1   Z   Na   22.0420  -18.5799 #+
            2   C1d C    17.9448  -17.2377
            3   P1b P    19.1457  -17.8735
            4   P1b P    16.7439  -17.8735
            5   C1b C    17.9448  -15.8956
            6   C8y C    19.1457  -15.1892
            7   C8x C    20.2760  -15.8956
            8   N5x N    21.4769  -15.1892
            9   C8x C    21.4769  -13.7763
            10  C8x C    20.2760  -13.0699
            11  C8x C    19.1457  -13.7763
            12  O1c O    15.5430  -17.2377
            13  O1c O    16.7439  -19.2863
            14  O1c O    15.1898  -18.8625
            15  O1c O    20.2760  -17.2377
            16  O1c O    19.1457  -19.2863
            17  O1c O    20.2760  -18.5799 #-
            18  O1a O    17.9448  -18.6506
            19  O0  O    23.0300  -20.0200
BOND        17
            1     2   3 1
            2     2   4 1
            3     2   5 1
            4     5   6 1
            5     6   7 2
            6     7   8 1
            7     8   9 2
            8     9  10 1
            9    10  11 2
            10    6  11 1
            11    4  12 2
            12    4  13 1
            13    4  14 1
            14    3  15 2
            15    3  16 1
            16    3  17 1
            17    2  18 1
///
